Cardioacc

Shenzhen, China · Founded 2021 · Privately Held (backing)

Developer of cardiovascular interventional imaging and treatment technologies designed to better treat patients. Cardioacc is based in Shenzhen, China and was founded in 2021. It has raised $14 million.

Last price · $/share
—
Implied valuation
—
Total raised
$14.0M
Last round
—

Who backs Cardioacc?

9 investors
InvestorType
YuanBio Venture CapitalVenture capital
Zhehua InvestmentOther
Far East Horizon—
Huaxin Capital—
Ltd—
Lucion Venture Capital—
Medtronic—
Tongfang Investment Co.—
Zhuhai Beiqinghe Investment Fund Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cardioacc investors

9 investors are on record for Cardioacc, including YuanBio Venture Capital, Zhehua Investment, Far East Horizon and Huaxin Capital.

Free account
More of Cardioacc with a free account
  • ·Watch Cardioacc: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Cardioacc. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View